Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00335452
Status:
COMPLETED
Last Update Posted:
2010-11-18
First Post:
2006-06-08
Brief Title:
Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTsOptimal Antiplatelet Strategy for InterventionS
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Randomized Multinational Double-blind Study Comparing a High Loading Dose Regimen of Clopidogrel Versus Standard Dose in Patients With Unstable Angina or Myocardial Infarction Managed With an Early Invasive Strategy
Status:
COMPLETED
Status Verified Date:
2010-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CURRENTOASIS7
Brief Summary:
The purpose of this study is to evaluate whether a higher dosage of clopidogrel with aspirin two doses will decrease the risk of ischemic complications cardiac death CV death myocardial infarction MI stroke after a percutaneous coronary intervention PCI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EUDRACT 2006-000313-38 | None | None | None |